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FLAX SUPPLEMENTATION
Abstract
We have become a society of convenience. Healthy foods that were staples for thousands of
years have become replaced by processed foods with long shelf lives. This has been done to the
detriment of our nutrition and health. Flax is one such replaced food item. A staple food for
hundreds of generations, flax had become scarce in our diet until recent interest spurred by
research found flax to be one of the best sourc es on earth for alpha-linolenic acid an Omegathree fatty acid, plant lignans, and contains a large amount of dietary fiber. Potentially these
constituents can have great health benefits for many health disparities such as cardiovascular

disease including hypercholesterolemia, as well as, conditions such as cancer, inflammation, and
bowel regulation.
The purpose of doing this review is to identify the proven benefits of flax supplementation to use
in primary care. The main search engines used to search the literature included PubMed,
CINAHL, and Google Scholar. The literature shows flax supplementation has proven LDL
cholesterol lowering benefits, bowel regulation benefits, inflammatory marker reduction, and
enormous potential for further research in many other areas. For this reason it is appropriate in
primary practice to support flax supplementation to promote normal cholesterol levels, and for
bowel regulation.
Key Words: lignans, flax, flaxseed, Omega-three Fatty acids, cholesterol, ALA, and
cardiovascular disease

FLAX SUPPLEMENTATION

4

A Review of the Benefits of Flax Supplementation
Cardiovascular disease is prevalent in our society with 26.6 million diagnosed as having heart
disease in the United States (CDC Fast Stats). This is due in part to diets high in Omega-six fatty
acids found in animal derived meat and fats. During the past decade studies have found that
supplementing the diet with foods rich in Omega-three fatty acids can help reduce the risk of
cardiovascular disease. Fish oil is one such food that is high in Omega-three fatty acids; however
there are concerns about the fish taste contained in fish oil supplements, industrial overfishing,
and contaminants such as mercury found in fish. For those who want an alternative to fish oil,
there is a common agricultural product that may also have cardioprotective Omega-three fatty
acids, anti-inflammatory lignans, and beneficial fiber. This product is flax.
Flax is a grain that has been grown domestically since at least 8000 BC. (NDSU, 2007). It has
been touted as a health food for hundreds of years; in the ninth century the Roman Emperor
Charlemagne believed in the benefits of flax so much that he enacted a law to force its
consumption among his constituents (Children’s Better Health Institute, 2005). The seeds can be
eaten whole or milled into flour, and the plant itself is very durable. In fact, flax has been used
to make linen and is currently used to make cigarette paper, due to its durability in thin layers.
Flax seeds are very high in fiber, protein, magnesium, thiamine, plant lignans, and Omegathree fatty acids in the form of Alpha-linolenic-acid (ALA) (Buse, et al., 2009). ALA is one of
only two essential fatty acids, meaning that it is needed by the body, however, the body is not
able to produce it. In order to be utilized, ALA must be converted to eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA) in the body (Consumer Reports on Health, 2009). Fish
oils are already high in the fatty acids EPA and DHA, but do not contain any fiber or plant
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lignans. Current studies on ALA attempt to not only determine the amount of ALA that is able to
be converted by the body, but also determine whether ALA has the benefits of EPA and DHA on
its own. In addition, there are questions about the potential benefits of the fiber and plant lignans
found in flax. This paper will attempt to identify the proven benefits of flaxseed product
supplementation.
Purpose
This independent study on flax supplementation will review the current literature in order to
fully understand the proven benefits of dietary supplementation with flaxseed and flax derived
products. The health aspects looked at for the use of flax supplementation include cardiovascular
health, type 2 diabetes mellitus, prostate cancer, inflammation, menopausal symptoms, and
bowel management. ALA, fiber, and lignans are the three components of flaxseed that will be
the focus of this review.
After completing this review, an educational pamphlet was created for use in clinical settings
to discuss the research findings on flax supplementation (see Appendix B). If the findings are
beneficial, methods in which to add flax to the diet, for example adding a tablespoon of ground
flax to oatmeal or yogurt, or potential ways to use flax in baking, may be included. The potential
recommendations for or against flax supplementation will be used for personal supplementation,
as well as, for future patients, colleagues, and family members. If there is not sufficient evidence
to support supplementation, or the evidence is not in favor of supplementation, flax
supplementation will not be recommended.
Significance
This study has the potential to impact nursing science and practice in a positive way by
improving the health of our patients. The science of nursing is a science that has health
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promotion at its core. It focuses on taking a primary preventative approach to illness rather than a
tertiary treatment approach. Dietary modification can affect several levels of prevention, it can
be used to help prevent disease altogether, or it can be used to maintain and improve disease
processes already at play. Flax supplementation could be one such dietary modification with
preventative and treatment properties. Some of the potentially beneficial ingredients include a
high amount of fiber, both soluble and insoluble, high concentrations of ALA omega-three fatty
acid, and antioxidant plant lignans of which flax has 800 times the amount of lignans found in
most other foods (Demark-Wahnefried, 2008). If flaxseed supplementation is effective at
improving health or quality of life, it has the potential to affect all areas of health care for the
prevention and treatment of disease.
This study is important in that it will demonstrate the potential benefits and or detriments of
flax supplementation. With Cardiovascular disease consistently being a leading cause of
mortality in the United States, a natural method of potential prevention is immensely important.
This is especially true when the method of prevention is generally easy, such as eating or taking
a supplement. If supplementation of flax may have the ability to help prevent cardiovascular
disease like fish oil, but does not have the mercury contamination, bad taste, or allergenic affect,
people may be more apt to adhere to a flax regimen. Also, there are a number of potential
benefits of the fiber in flax. Much of the population requires fiber supplementation and or
laxative use in order to maintain regularity of bowel movements and prevent constipation. Flax
could potentially solve this problem without unnatural, and possibly detrimental, pharmacologic
interventions. In addition, flax lignans have the potential to act as antioxidants that could prove
to have many potential benefits, the extent of which are unknown.
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While this study will not generate new results or uses for flax, it will compile the results
already available making them easier to compare and contrast. In addition, it will help to
determine the proven benefits of flax, the quality and reliability of the current information, and
whether there is a need for further study before determinations on flax supplementation can be
made.
Theoretical Framework
The theoretical framework used for this review is based on Betty Neumann’s Systems model.
This model uses the concepts of client whol eness, the goal of optimal health and utilization of
primary prevention strategies to maintain wellness (Neumann & Reed, 2007). This model’s focus
is not only on prevention, but also on stress, reaction to stress, and the constant continuum
towards and away from health and illness (Western Governor’s University College of Health,
2011 ).

Neumann’s continuum of illness and wellness is influenced by factors such as diet. Dietary
intake can have positive or negative impact on health by influencing cholesterol, laxation, and
inflammation. In the absence of disease, flax supplementation has the potential to provide a
positive mode of primary prevention by maintaining normal cholesterol levels, normal healthy
laxation, and potentially preventing inflammation and the numerous health disparities associated
with inflammation. In the presence of disease, flax supplementation can provide tertiary
prevention, which involves treating conditions such as hypercholesterolemia by reducing
cholesterol, constipation by increasing ease of laxation, and conditions characterized and
exacerbated by inflammation. In either circumstance, flax supplementation has the potential to
help maintain or trend towards a healthier state (Western Governor’s University College of
Health, 2011).
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Definitions

In writing this review there are several terms that require definition and clarification in order
to achieve understanding of the concepts inclu ded. These terms include Omega three fatty acids,
Alpha-linolenic acid (ALA), Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA), fiber,
and lignans.
1) Omega-three fatty acids: are polyunsaturated fats derived from fish and many plant sources
such as flax, sunflower, com, soybeans, olives, and canola.
2) ALA: Alpha-linolenic acid (ALA) is an essential omega-three fatty acid found in high
concentrations in flaxseed oil. There are questions about whether or not ALA has any beneficial
health effects in the body, or if it needs to be converted to EPA and then DHA before it can be
beneficial.
3) EPA: Eicosapentaenoic acid is a beneficial Omega-three fatty acid found in fish oil. EPA
can be converted to DHA, which is proven to be more beneficial than EPA. Some evidence
exists that ALA is able to be converted to EPA and DHA.
4) DHA: Docosahexaenoic acid (DHA) is an Omega-three fatty acid, a polyunsaturated fatty
acid, which studies show to be responsible for the antiatherogenic abilities of fish oil (Alternative
Medicine Review, p. 391). It has also been established as the fatty acid responsible for raising
HDL cholesterol, and lowering LDLs and triglycerides.
5) Fiber: fiber is found in most plant products. It is indigestible and helps prevent constipation
by adding bulk to the stool and aiding in defecation. The fiber content of flax is 28% by weight,
33% of which is soluble fiber, which may have the potential to improve insulin sensitivity and
lower cholesterol (Bloedon, 2008). Soluble fiber attracts water, turning into a gel in the GI tract
which adds to bulk and aids motility of the stool.
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Lignans: lignans are compounds that naturally occur in plants. Some plant lignans can be

converted into enterolignans by intestinal flora and absorbed in the blood stream. Studies
suggested that high serum concentrations of enterolactone, an enterolignan, are associated with a
lower risk of acute coronary events. “Associations between enterolignans and cancer are less
clear,” (Kuijsten, Arts, Van’t Veer, & Hollman, 2005, p. 2812 ). “Among foods consumed by
humans, flaxseed contains the highest concentration of enterolignan precursors,” (Kuijsten, et al.,
2005, p. 2812). Flax contains over 800 fold the dietary lignan than are contained in most other
foods (Demark-Wahnefried, 2008)
Review of Literature
Purpose
The majority of flax supplementation research has been done with the focus on
cardiovascular health. In 2008, Bloedon set out to research the effects of flax compared to the
effect of wheat bran supplementation on fasting lipoproteins, insulin resistance, inflammatory
markers, and oxidative stress. Patade (2008) has also conducted research to determine whether
30g of flaxseed would have an effect on the lipid profiles of postmenopausal Native American
women. Lucas conducted a study in 2007 with the goal of comparing the cholesterol and lipid
lowering cardiovascular benefits of 40g ground flax supplementation to the benefits of ground
wheat. Lucas also set out to determine whether there were estrogenic or anti-estrogenic effects of
the lignans, which potentially could have anti-osteoporotic benefits. Dodin, Lemny, Jacques,
Legare, and Masse also attempted to find the effect of lignans on lipids, as well as, the
phytoestrogenic effect from flaxseed supplementation (2005).
Several other studies have been done on the efficacy of differing types of flax
supplements. One such study by Austria et al. (2008) was focused on determining the efficacy of
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absorption with the different modes of flax supplementation using 6g flax oil, 30g milled flax
seed, or 30g whole flax seed. The intent was to determine the best method of supplementation
with regards to ALA absorption, in addition to the effects of each product on cholesterol lipids
and platelet aggregation. Some of the studies have been done using flax oil supplements alone.
Barcelo-Coblijn et al. (2008) conducted a study in Winnipeg, Manitoba with assistance from the
University of North Dakota which compared the effects of fish oil to flaxseed oil in varying
amounts. This study was done with firemen who were at risk for cardiovascular disease (CVD).
Flax studies have been done to determine benefits for conditions other than CVD as well.
Demark-Wahnefried (2008) produced a study to determine the effect of flax supplementation on
prostate cancer proliferation in patients diagnosed with prostate cancer awaiting prostatectomy.
This arose because flax is a substantial source of fiber and plant lignans, which may have
“antimitotic, antiangiogenic, antioxidant and phytoestrogenic effects” which could be beneficial
to cancer patients (Demark-Wahnefried, 2008, p. 3577). Hallund studied the effects of plant
lignan supplementation on markers for vasoconstriction and inflammation (2006). Another study
regarding the benefits of flax lignans by Pan et al. was to determine the effects of flax lignans on
people with type 2 diabetes mellitus, based on the protective antioxidant effects associated with
lignans (2007). Dares-Dobbie conducted a study on bowel movement patterns and the need for
pharmacologic laxative interventions while supplementing nursing home residents’ food with
ground flax. This was done to see whether large amounts of fiber, both soluble and insoluble,
would decrease the incidence of constipation (2006). Wang’s study focused on determining
whether the bacteria in the human GI tract could effectively convert the lignans to a more bioavailable form to be used in the body (2010).
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Designs
Of the 12 clinical studies used in this review, all but two of them were double blind
randomizd controlled clinical trials in which a control group was used, as well as, at least one
flax supplement group. Of these, one was a randomized, double-blind, cross-over study in which
each group took an eight week stent of being the control group. The amount of flax
supplemented in these studies ranges from 30-40g of whole flaxseed or ground/milled flax, or
1.2-6g flax oil and 360 -500 mg flax derived lignan supplement. In most of the studies, the flax
products were used in baked goods to improve adherence and hide the identity of each groups’
supplement. The durations of these studies varied; a presurgical study averaged 21 days,
although most were 10-12 weeks, and one lasted a full year. All studies involved periodic blood
sampling alone and some used urine collection in addition to measure lignan metabolites to
determine adherence to the diet.
There were two studies in the review that were not randomized controlled trials, they were,
however, repeatable clinical trials. One study involved the effect of incorporation of flax into the
diet on bowel habits. For this study, the design was to record normal bowel habits and
pharmacologic interventions for one month. Then, two months later, flax was added to the diet
and bowel habits and interventions were recorded again for another month. This group was
supplemented with two tablespoons of flaxseed every morning. Blood testing was not done in
this study. The other non-randomized study took fecal samples from healthy young adults and
colonized the bacteria, combining the bacteria with flax lignans to determine whether the GI
flora could convert them to more potent and bio-available lignans.
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Samples
According to Pan (2007), a sample of 67 was needed to maintain a one sided, 5%
significance level for his crossover trial to allow for the chance of a 10% dropout rate. Sixty
eight participants completed the Pan study. No other researchers reported the number of
participants needed to maintain significance in their studies. Several of the studies had less than
55 participants; one was Austria’s study in which there were only 30 participants separated into
three groups, Dares-Dobbie’s (2006) study on constipation which included only 12 participants,
and Hallund, Tetens, Bugel, Tholstrup and Brunn’s (2008) study which included only 22 healthy
postmenopausal participants. The study by Dodin (2005) included the most participants with
199 healthy postmenopausal women starting the study and 179 finishing the study. Demark Wahneffied (2008) had the second largest number of participants with 161 starting the study and
149 qualifying to finish the study. In several studies approximately 10% either did not return,
dropped out, or were eliminated after being judged to have not adhered to the diet according to
self reporting questionnaires and urine testing. The following inclusion criteria were used for
many of the studies: age, menopausal status, cholesterol and lipid levels, health status, not
currently using supplements, not using hormone replacement therapy, and one study included all
subjects with prostate cancer scheduled for prostatectomy.
Measures
All but one of the studies used blood testing to determine the effects of the flax
supplementation. For these studies blood was tested at induction and again at the end of the
study, and most also tested blood at least once during the supplementation. One study by
Barcelo-Coblijn (2008) tested blood every two weeks for the 12 week period. In most studies,
lipid panels were measured, but individually they also tested red blood cell fatty acid content,
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insulin resistance (HOMA-ir), Hemoglobin A1C (HgA 1C), fasting glucose levels, insulin levels,
inflammatory markers, oxidative stress markers, hormones, platelet aggregation, ALA levels,
bone density tests, side effect journals, menopausal symptoms, and tumor proliferation markers.
When urine was tested, it was tested for lignan metabolites to determine the amounts of flax
consumed. Only one study, conducted by Dares-Dobbie (2006), did not measure blood or urine,
but instead recorded bowel movements, reports of constipation, and use of pharmacologic
interventions for bowel movements.
Approaches to Analysis
Analysis of variance (ANOVA) was used in the analysis of the data for six of the studies.
The study by Bloedon (2008) was one of those; their study included both a primary and
secondary stance. The primary stance was the information from all of the participants, the
secondary was the findings of the participants who adhered to the diet more than 80% of the
time, and the results were significantly different with adherence factored in. For most of the
studies, only data from participants who finished the study were used. Several of the studies,
however, did not mention the dropout rate, or possible nonadherance. The Dares-Dobbie (2006)
study did not discuss their approach to analysis. Demark-Wahnefried’s (2008) study analysis was
based on intent to treat. Dodin (2005) and Hallund’s (2006) studies used SAS statistical
software.
Findings
Bloedon (2008) found ALA increased and omega-six fatty acid decreased in the flax group.
At five weeks LDL was significantly reduced compared to the control group, and at 10 weeks,
factoring in adherence, LDL levels were still significantly reduced. HDL levels reduced in men,
but no change in HDL was found in women, and HDL levels were unchanged in the control
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groups. There was no change in insulin sensitivity in either group. Flaxseed led to reduced
inflammatory markers in those with hypertension, while inflammatory markers increase in the
control group. With regard to inflammatory markers, 62% of the flax group vs. 32% of the
control group responded favorably. Bloedon found there was a reduction in LDL at five weeks
and it returned to baseline by 10 weeks, probably due to reduced dietary adherence. For this
reason, the significance of this study was questioned. Further research should be done to repeat
this study with greater methods of adherence testing, such as testing urine lignan metabolites.
Patade (2008) found that both flax groups had a total cholesterol level drop of 7%, without
significant change in the control. LDL was reduced by 10% in the flax groups, without change in
control group. HDL decreased by 17% in the control group, without change in the flax groups.
Triglyceride levels increased by 18% in the control group, but only by 3% in the flax, and 8.5%
in the flax and fiber group. Flax supplementation demonstrated no estrogenic effects. This study
was sound, but concerns were noted. The study began with 55 subjects and ended with 42
subjects, which calls into question whether there were enough participants to be entirely valid.
Also, there seems to be no method of determining the adherence of the individuals other than
through random phone questionnaires.
Lucas (2002) found that the flax group had a 6% decrease in total and non-HDL cholesterol
levels. LDL decreased by 4.7% (not significant), and triglycerides decreased by 12.8% (also not
significant). HDLs were somewhat lowered by flax. APOa-one and APO-b (cholesterol
precursors) were significantly reduced by flax and unchanged by wheat. No changes were found
in markers of bone metabolism, which meant no benefits of the phytoestrogenic lignans on bone
metabolism were found. This was a good study that found reductions in cholesterol and
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cholesterol precursors. While LDL and Triglycerides were not reduced enough to be significant,
their reduction is still beneficial. Lucas’ study was good with sound subject numbers and criteria.
Austria et al. (2008) found that more ALA could be absorbed from ground flax than whole
flax. Flax oil produced the highest rise in ALA, but milled flax was almost as effective. Milled
flax had all the benefits of fiber and lignans, and produced a three fold increase in plasma ALA
over baseline levels. EPA and DHA did not change in the plasma lipid panels. No changes in
platelet aggregation or bleeding times were found. No changes in lipids or cholesterol were
found in the healthy, young, normolipidemic, normocholesterolemic men. As far as ALA
absorption, milled flax and flax oil are highly effective flax supplements. No changes in lipid
panels were found, possibly due to healthy participants with normal lipid values.
Barcelo-Coblijn (2008) found the consumption of ALA enriched supplements for 12 weeks
was sufficient to elevate red blood cell levels of EPA and DHA, showing the effectiveness of
ALA conversion. The amounts of ALA required to do this are easily achieved in the general
population with dietary modification. There was no difference in lipid profile or plasma
inflammatory markers between fish and flax oil groups. Fish oil groups had faster rises in
Omega-three fatty acids in the bloodstream and the higher levels were maintained. This study
illustrated that flax oil can produce much of the benefits produced by fish oil, however more
research needs to be done on the effectiveness of ALA conversion to EPA and DHA, and
whether intercellular EPA and DHA conversion in the red blood cells has the same effect as
when dissolved in the plasma, which is measured by most lipid panels.
Demark-Wahnefried (2008) found the flax supplementation, rather than a low fat diet,
showed positive effects in decreasing the tumor proliferation rates in men with prostate cancer.
Tumor proliferation rates were measured by counting Ki-67 positive cells (an indication of
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cancer growth) in the prostate specimens after prostatectomy. They found that those who ate flax
and a low fat diet had 1.50% of cells Ki-67 positive, 1.66% in the flax and regular diet group,
and 3.23% in the regular diet control group . Only low fat diets showed effects on cholesterol,
which may potentially be due in part to the short duration of supplementation. This study
included the highest number of participants and had some very significant findings, but was
limited to the short duration of the presurgical timeframe average of 21 days. More research is
needed on the full effects of lignans in order to utilize them to their full potential.
Pan (2007) found that by supplementing people with type 2 diabetes mellitus with flax
derived lignans, they had significantly improved HbAlc levels, which is an indication of
glycemic control. Homa-insulin resistance was reduced by 3.3% compared to baseline. Fasting
glucose and insulin concentration levels were also reduced, but not significantly. There were no
changes in the lipid panels, perhaps due to the lack of fiber and ALA found in flax, but absent
from the isolated lignans. This study had enough participants and thorough analysis to be judged
a reputable resource, however, more studies on the benefits of lignans are needed as there is
currently very little available.
Dares-Dobbie (2006) found that during the flax supplementation phase there were no reports
of constipation. During supplementation there was a 95% decrease in laxative use and 42% of
participants increased frequency of bowel movements, while 48% had decreased frequency of
bowel movements. Results showed that, in these patients, adding flax often decreased bowel
movements but increased ability to have bowel movements without intervention. This study was
very limited in its resource value. While the concept is good, and the information is good, there
was no discussion of necessary sample size, and this study was small with only 12 participants.
More research with larger samples and more analysis is needed for flax and bowel care.

FLAX SUPPLEMENTATION

17

Dodin’s (2005) study is the largest of the group, with 199 postmenopausal women spanning
one year of supplementation. While they did not demonstrate any change in bone mineral density
or menopausal symptoms, the women in the flaxseed group had a significant decrease in total
cholesterol of 0.2mmol/L (or 8 mg/dL). Initially systolic and diastolic BP were both reduced by
4 mm/Hg to 5 mm/Hg in the flax group, with no change in the placebo, but these numbers did
not carry through to the end of the study. In addition, this study showed a slight decrease in HDL
of 0.08mmol/L or about 3 mg/dL as well (Dodin, 2005). More study is needed in the effect of
flax on hypertension.
Hallund (2006; 2008) produced two studies with the same study group, through testing for
different factors; one for inflammation, and one for vascular endothelial constriction. While they
found the C-reactive protein, a marker of inflammation, decreased by 15% through flax
supplementation, they did not find any significant change in markers of constriction. This sample
size was small, at 22 participants, but the results are significant and warrant further study.
In order to determine the bioavailability of the lignans found in flax, as well as, to determine
whether the flora found in human intestinal tracts are sufficient to convert lignans into their
usable forms, Wang et al. conducted a study in 2010. They found through culturing and isolating
human fecal bacteria, it was possible to isolate groups of bacteria that convert flax lignans into
potent bioavailability lignans. These bacteria were found to be more efficient and effective at
converting flax lignans than can currently be done synthetically. This study has proven the
effectiveness of the conversion of flax lignans in the human GI tract, as well as, the possibility of
future commercial production of lignans through bacterial conversion.
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Findings of Reviews
Bassett, Rodriguez-Leyva, and Pierce (2009), in doing a systematic review on flax
supplementation, reviewed 53 articles on the subject. They found that ground flaxseed could
reduce total cholesterol 6-11%, LDL by 9-18%, and could lower markers of atherosclerotic
cardiovascular disease. The hypocholesterolemic effect was most likely associated with the fiber
and lignan content of the ground flax. There were also anti-inflammatory, antiatherogenic and
antiproliferative effects of flax supplementation which were attributed to the ALA Omega-three
fatty acids. This review supported the idea that ALA is a cardioprotective Omega-three fatty
acid, like EPA and DHA from fish oil. This review also suggested further study of flax
supplementation in patients with atherosclerosis.
Prasad et al. completed a review of flax supplementation in 2009 which references 96 articles
on the subject of flax supplementation and cardiovascular disease. Their findings suggested that
flaxseed constituents such as fiber and lignan, but not flax oil, can suppress atherosclerotic heart
disease, but can’t regress it. They linked the suppressive effects to the lignan rather than the ALA
content of flax. They found that flax that is low in ALA, and lignans can significantly lower lipid
levels, but these effects are variable. ALA in high doses suppressed inflammation, decreased
platelet aggregation and increased bleeding time. Their findings suggested that the components
of flaxseed may be effective in cardiovascular health.
Pan, Yu, Demark-Wahnefried, Faranco, and Lin, in their 2009 review, critiqued 28
studies spanning the last 20 years in order to compile the proven effects of flax derived
supplements on lipids. This review found whole flaxseed reduced LDL by 0.21 mmol/L and 0.16
mmol/L, flax lignans reduced LDL by 0.28 mmol/L and 0.16 mmol/L, but flaxseed oil showed
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no effect on LDL. They did not find that any flax derived intervention effected HDL or
triglycerides significantly.
Characteristics of individual studies included in this paper are presented in Table A1
Summary o f Study Characteristics (Appendix), which lists studies by author and includes the
types of study designs used, conclusions of each of the studies, and comments and opinions
about each of the studies.
Methods
This review began with searches on several databases, mainly CINAHL, PubMed, and

Google Scholar. Keywords used in the search included flax, flaxseed, Omega-three Fatty acids,
cholesterol, ALA, and cardiovascular disease. When possible, the limitations of Peer Reviewed,
PDF full text available, human studies, trial studies and English language were used. The initial
searches in CINAHL resulted in very limited results yielding only five usable articles, however,
PubMed had many more. Google scholar results brought up many of the same articles from
PubMed and CINAHL, but few were able to be accessed. Through the searches, many relevant
articles were found. Using the references from several of those articles led to the retrieval of
several others that had not originally shown up in the searches.
Researching flax supplementation the main focus was on articles and studies that, in general,
compared flax to a control which consisted of substances known to have little benefit in
cholesterol management, such as wheat bran. In using these studies, any effects of the flax
should be clear when compared against the control, as the control should have no significant
effect of its own. Few studies were included that compared flax to another treatment modality
such as fish oil. One such study did compare the two, but had flax as the primary focus and did
not diminish the flax oil effects. Only human trials were included. Not all studies had a control,
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but the ones selected for this review were current, and involved flax supplementation in the form
of whole flaxseed, ground flax, flax oil, or flax derived lignan.
A poster was created which basically provided a summary of the review as of April 2010.
This poster was completed with an overview of the reasons that flax is being studied, which
included the potential benefits of ALA, lignans, the soluble and insoluble fiber, and the best form
in which to supplement flax. An in-depth review of the studies reviewed was also included. The
proven benefits of flax supplementation were highlighted along with considerations for practice
and intentions for a final product.
Results
In order to determine the effectiveness of the pamphlet, it was posted to an evidence based
practice graduate level nursing class blog. The purpose of this was to obtain peer reviews of not
only the pamphlets presentation, but of the content as well. In total, five peers viewed and
commented on the pamphlet. Most comments were very positive, with several constructive
comments on the need to reduce the information posted in the body of the pamphlet. These
comments were taken into consideration and edits were made to make the pamphlet easier to
read and comprehend.
Using the information found in this review and the pamphlet created, education will be
provided to both patients and colleagues on the benefits and indications for flax supplementation.
This information will be introduced into practice and both this review and the pamphlet will be
available for patients and practitioners to use at their discretion. Also, this information can be
used to create and present a presentation about flax supplementation geared towards either
patients or providers.
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Discussion and Implications for Nursing

Practice
The findings of the studies reviewed indicated there is great potential for flax
supplementation with regards to cholesterol management. Studies have shown modest
improvement in both total cholesterol, and LDL cholesterol through flax supplementation. For
this reason practitioners should advise the addition of flax in the diets of patients who wish to
maintain a normal cholesterol level, as well as, those who need to reduce their LDL cholesterol.
For patients who use pharmacologic bowel regulation measures, trialing flax
supplementation in lieu of pharmaceutical methods could be suggested. While the bowel health
study reviewed was limited in its size and analysis, the findings were valid. Personal experience
supplementing the diet with ground flax can have tremendous abilities in the prevention of
constipation, with fewer episodes of gastronomic disturbance and flatulence than many highfiber foods on the market today.
Research
While the findings of the studies have proven there are benefits to flax supplementation, the
full extent of the benefits are not fully understood. This is especially true of the benefits of
lignans found in the flaxseed. Flax has the highest concentration of lignans of any organic food
source. Additional questions regarding flax lignans include: how beneficial are lignans? What
health conditions can lignans provide protection from? and what conditions are they able to
treat? In order to answer these questions more research is required.
In addition, the full effects of the ALA found in flax are still not fully understood. More
research is needed in order to determine the body’s abilities to utilize ALA for a significant
benefit. Debate also continues about the cholesterol lowering abilities of flax being either an
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ALA or lignan/fiber benefit. These questions need to be answered and the only way to
accomplish that is through more research.
The final area of flax supplementation that has greatly overlooked potential is the bowel
management properties of the fiber found in flax. The one study reviewed was very small in
sample size and low in analytical discussion, the results were very clear, but more study is
needed to determine just how effective flax supplementation is in treatment of constipation and
bowel regulation. From personal experience supplementing a diet with flax, it has tremendous
abilities in the prevention of constipation. However more research showing its full effectiveness
would be very beneficial.
Education
Education on dietary modification is necessary in order to promote inclusion of flax in the
diet. Ground flax has a relatively short shelf life, and must be used or frozen within a month after
grinding or opening. Also, it is necessary to start with a small amount of flax and increase to a
total of two to four tablespoons per day in order to acclimate to the large amount of fiber without
abdominal discomfort. Adequate hydration is necessary with all high-fiber diets in order to
prevent constipation.
Ways in which to include flax in the diet are often simple, such as adding ground flax to
yogurt, cereal, or oatmeal. It can also be mixed in condiments such as mustard or mayonnaise
and used in a sandwich. It can be used in baking as well, either as an addition to the ingredients,
or as a substitute for eggs or cooking oil. One tablespoon of ground flax with three tablespoons
of warm water, when mixed and allowed to sit, can be substituted for an egg (Buse et al., 2009).
One cup of flax flour can replace one-third cup of cooking oil (Children’s Better Health Institute,
2005). Imagine the health benefits of using less cooking oil and more flax in our everyday diet.
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Flax should be a mainstay in baked goods; all it takes is a little education on our part and the
parts of dieticians in order to get more people to consume more flax.
Health Policy
Flax supplementation would not require much in the way of health policy change, rather the
extent of its benefits are in need of further study, and more dietary inclusion. Once flax benefits
are fully known, it could become a staple health food that would be recommended in many areas
of healthcare. Policy should not be affected except in facilities whose policies would change in
order to include flax in their diet.
Summairy/Conclusions
In conclusion, flax supplementation is a topic of debate for good reasons. It has been
linked to improved cardiovascular health through the anti-inflammatory, antiatherogenic and
antiproliferative properties of ALA. Also, it has anticholesterolemic properties through ingestion
of the lignans and fiber. The full benefit of ALA and lignans in humans is still not fully
understood, but additional research should determine the full extent of ALA function and use.
The cardiovascular effects of flax supplementation are only the tip of the iceberg as far as the
potential benefits of flax goes. Flax also has tremendous potential for beneficial effects on bowel
management, diabetes management, and reduction of tumor proliferation rates. Some of these
benefits are not fully understood and will require additional research in order to determine the
extent of the benefits and what conditions may benefit from flax supplementation.
Phytoestrogenic effects were not shown in any of the studies reviewed, so flax should neither be
used for nor contraindicated by phytoestrogenic effects.
Flax supplementation shows great promise. Currently there is sufficient evidence showing
that flax has benefits for both cardiovascular health, in the form of cholesterol management, and
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bowel health, in constipation management. Among flax supplementation, ground flax is
considered the best medium of supplementation due to the availability of the ALA to be
absorbed easily, as well as, the presence of the fiber and lignans.
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Appendix

Table A 1
Summary o f Study Characteristics Table
Author(s),
Year
Bloedon, L.,
et al. (2008).

Patade, A.
(2008)

Lucas, E., et
al. (2002).

Austria, J. et
al. (2008)

Description of Study

Conclusions

Randomized clinical trial
using 62 men and post
menopausal women.
Randomly given 40g/day of
flax supplementation.

Ground flaxseed has a
Good study with
modest but short lived
clinical testing but
LDL-C lowering effect,
indicates further need
yet reduces inflammatory
for testing.
markers and improves
insulin sensitivity in
hyperlipidemic adults. The
HDL-C lowering effect of
flaxseed in men warrants
additional study.

Randomized clinical trial 55
female Native American
postmenopausal women
with hypercholesterolemia
given 30g flaxseed, oat
bran+ flaxseed, or a control
supplementation for three
months.
Randomized clinical trial,
58 postmenopausal women
consumed 40g of flax or
wheat substitute daily for
three months.

Results in flaxseed group
showed a 7-10% decrease
in LDL levels. HDL and
triglycerides remained
unchanged.

Good article, good
sample, and good
time frame.

Flaxseed supplementation
lowered total cholesterol,
and non-HDL. The
control regimen had no
effect. Flaxseed regimen
reduced serum levels of
both LDL and HDL. Bone
formation markers not
affected by
phytoestrogenic effects of
flaxseed supplementation.
Were able to extract more
ALA from ground flax
than flax. Oil produced
highest rise in ALA, but
has low shelf life. Milled
flax has all the benefits of
fiber and lignans with
three times the increase in

Good study covering
a longer study period
and higher number of
subjects than the
study by Hallund.

30 healthy volunteers ages
18-49 randomly assigned to
three treatment groups,
ingesting whole flax seed,
milled flax seed and flax
seed oil in baked goods.
Over a period of 12 weeks.

Comments

Gastrointestinal
disturbances found to
hinder compliance in
whole seed group.
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BarceloCoblijn,G.
(2008)

DemarkWahnefried,
W. (2008)

DaresDobbie, E.
(2006)

Study involving six groups
consisting of 9-12 Winnipeg
firefighters over age 40 not
on medication, exercising,
and eating a high fat diet.
Control group had 1g
sunflower oil supplement.
Flax oil groups were
supplemented with
1.2g/day, 2.4g/day, or 3.6
g/day. Fish oil groups
supplemented with 0.6g/day
or 1,2g/day. Blood was
tested every two weeks for
12 weeks. Study protocol
approved by UND and
blood samples tested at
UND.
Randomized controlled
clinical trial to test effects of
a regular diet, a low fat diet,
low fat diet with flax seed
supplementation or flax seed
supplementation with a
regular diet on 161
individuals with prostate
cancer prior to
prostatectomy. Average 30
days from initiation to end
point. Levels were measured
for PSA, LDL, cholesterol,
testosterone, insulin-like
growth factor-one, and the
tumor marker Ki-67. 149
participants finished the
study.
Non randomized clinical
trial of flax supplementation
in food cooked in a nursing
home for willing

plasma ALA. EPA and
DHA did not change. No
change in platelet
aggregation or bleeding
times. No change in lipids
or cholesterol.
The consumption of ALA
enriched supplements for
12 weeks was sufficient to
elevate red blood cell
levels of EPA and DHA
showing the effectiveness
of ALA conversion. The
amounts of ALA required
to do this are easily
achieved in the general
population with dietary
modification. There was
no difference in lipid
profile or plasma
inflammatory markers
between fish and flax oil
groups.

Shows that ALA can
be effective like fish
oil. However, found
fish oil increases
levels more quickly
and maintain levels
higher than flax oil.

The flax groups had
significantly lower tumor
proliferation rates which
were 1.5 For flax and low
fat, 1.66 for regular diet
and flax, 3.2 for the
regular diet without flax,
and 2.56 for the low fat
diet without flax.
Cholesterol decreased in
low fat diet.
Flax may be protective
against prostate cancer.

Large study sample,
short time frame,
good results and
repeatable study.

Laxative use decreased by
95% during flax
supplementation. Half had
increased bowel

Very interesting
study with enormous
potential for impact
in the elderly
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Pan, A., et
al. (2007)

Dodin, S.,
et al. (2006)

Hallund, J.,
et al. (2006)

Hallund, J.,
et al. (2008)

participants, comparison of
bowel movements, PRN
laxative use, over a month’s
time before and after flax
supplementation.

movements with flax, half
had fewer. None reported
constipation during the
flax supplementation.

population. Also a
great benefit for those
with bowel
irregularity. Good
study on secondary
benefits of flax.

Randomized, double-blind,
cross-over trial for the use
of flax lignan supplement on
type two diabetics. 37 took a
360mg flax lignan pill and
36 took a placebo for 12
weeks, took eight weeks off
then the groups switched for
12 weeks. Urine tests
validated adherance in
lignan group.
A randomized double-blind
clinical study in which 199
healthy menopausal women
were assigned to 40 g flax
or wheat germ placebo for
12 months. Menopausal
symptoms, lipids, and bone
mineral density at were
recorded at onset and at 12
months.
Randomized, double-blind,
placebo controlled crossover
study in which 22
postmenopausal women ate
muffins daily with or
without the flax derived
lignans. Blood draws were
taken to measure markers of
vascular endothelial
constriction.
Randomized, double-blind,
placebo controlled crossover
study in which 22
postmenopausal women ate
muffins daily with or
without the flax derived
lignans. Blood draws were
taken to measure C-reactive

Lignans reduced Homainsulin resistance by 3.3%
compared to baseline.
Fasting glucose and
insulin concentration were
also reduced, but not
significantly. By week 12
HgAlc was significantly
reduced.

Study had good
findings, and
information regarding
why they chose the
number of
participants and how
they chose the
amount of lignan.

Flaxseed reduced total
choleseterol,0.2 mmol/L,
and HDL 0.08 mmol/L.
There was no change in
bone mineral density.
Similar reductions in
menopausal symptoms
were found in both
placebo and flax groups.

Good size and
duration of study,
shows good decrease
in total cholesterol.

This study showed no
significant change in the
markers of vascular
constriction.

Small sample size,
but otherwise good
study, shows that
lignans probably do
not reduce
endothelial
inflammation.

This study did show a
significant difference of
15% in CRP levels from
the flax lignan group in
comparison to the placebo
group.

Small sample size,
but otherwise good
study, shows that
lignans probably do
reduce inflammation.
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Wang, C.,
etal. (2010)

protein (CRP) a marker of
inflammation.
Clinical trial of producing
enterodiol, an effective
antioxidant from defatted
flax seeds by using human
intestinal bacteria.

This study found that the
intestinal bacteria cultured
from fecal matter of
healthy young adults, is an
effective, efficient and
eco-friendly way to
convert flax lignans to
enterodiol, a potent
antioxidant.
Flaxseed interventions
reduced total LDL
concentrations by 0.1 and
0.08 mmol/L, Whole
flaxseed by 0.21 and 0.16
mmol/L, flax lignans by
0.28 and 0.16 mmol/L, but
flaxseed oil showed no
effect on LDL. No flax
derived intervention had
significant effect on HDL
or triglycerides.

This clinical trial
isolated the bacteria
in order to determine
which combination of
bacteria yields
enterodiol.

Evidence suggests that
ALA and lignans provide
hypercholesterolemic
action. ALA contributes to
the antiatherogenic effects
of flaxseed via anti
inflammatory and
antiproliferative
mechanisms.
Review of studies on the
Flaxseed, not flax oil can
effectiveness of flax seed
suppress the development
supplementation on
of atherosclerosis, but do
cholesterol in humans and
not regress
animals. Discusses contents atherosclerosis. Flaxseed
of flax including cyanide.
oil in large quantities can
Eating one kg per day could suppress inflammatory
cause problems in regards to mediators and decreases
cyanide toxicity.
platelet aggregation.
Flaxseed oil may interact
with anticoagulants.
Review finds flax may be

Good review
covering many of
above articles as well
as many more that
were unavailable to
me.

Pan, A., et
al. (2009)

Literature review including
28 studies dating from
1990-2008. Review covered
whole flax seed, flax
derived lignans and flax
seed oil supplements effect
on adult lipid profiles.

Bassett, C.
(2009)

Review of clinical dietary
intervention trials. 53
references.

Prasad, K.
(2009)
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This review was
fairly comprehensive
and used the Jadad
score in order to
determine validity of
the studies.

Very thorough
review. 96
references. States
good and bad
qualities of flaxseed
supplementation.
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Why consider flax
supplementation!*
Like fish oil, flax is high in
omega-3fatty acids. However
flax also contains fiber, lignans
which can act as antioxidants,
and are a good option for those
allergic to fish.

How flaxseed
can benefit vour
health.
J

Flax can help lower cholesterol.
Flax can help prevent
constipation.

North Dakota Flax Field

Flax has potential to reduce
systemic inflammation.
F.asy to supplement and
incorporate in diet.

V l AXS BED

S U V P L EM E N T A X I O M

Samuel P. Held RN BSN FNPS
University of North Dakota
430 OxfortStStop 902J
Grand Forks, ND <8202

Flax Bread

Benefits of flaxseed
supplementation.

Tips for supplementing with
flaxseed.
Add ground flax o r flax flour to cold cereal,
yogurt, oatmeal, o r condiments such as
ketchup , mustard, o r mayonnaise.

• Ground flax supplementation is
proven to:
• Lower total cholesterol by as much
as 6-11%.
• lowers LDL cholesterol by as much
as 6-18%.
• Reduce incidences of constipation
and. need for laxative use.
• Improve markers of systemic
inflammation.

Flaxseed before and after grinding.

How to supplement with
flaxseed.
Flax is belt supplemented at ground flax and
flax flour as it has a fibrous shell that must be
broken before the contents can be digested.

Replace 1/ i cup o f oil with one cup
o f flax flour in baked goods.

Replace Eggs in baked goods by combining
1 tablespoon o f G iouud Flax with J table
spoons o f water, let it sit for a few minutes
before adding.

Flaxseed contains a large amount o f fiber,
when you start to use flax start with one tea
spoon o f flax flour, and gradually increase up
to 2 tablespoons to avoid gas o r abdominal
discomfort.

Flax flour can go rancid faster than tegular
flour, for this reason it may be best to buy
whole flaxseed which has a long shelf life
then grind it in a coffee grinder prior to use.

Flax flour will last longer if stored in the

Ground Flax

Flax Buns
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